Previous
Previous

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma …

Next
Next

Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials